BIT
NDRM

BlackRock Institutional Trust’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

BlackRock Institutional Trust’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.76M Buy
79,352
+28,539
+56% +$534K ﹤0.01% 3098
2016
Q3 		$940K Sell
50,813
-581
-1% -$10.1K ﹤0.01% 3321
2016
Q2 		$835K Buy
51,394
+21,695
+73% +$365K ﹤0.01% 3373
2016
Q1 		$419K Buy
29,699
+1,862
+7% +$25.2K ﹤0.01% 3494
2015
Q4 		$475K Buy
+27,837
New +$542K ﹤0.01% 3518

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Institutional Trust's NDRM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its NeuroDerm Ltd. Ordinary Shares (NDRM) stake by 56% in Q4 2016, buying an estimated $534K and bringing the position to 79,352 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

BlackRock Institutional Trust first reported a position in NDRM in Q4 2015 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • BlackRock Institutional Trust held 79,352 shares of NeuroDerm Ltd. Ordinary Shares worth $1.76M as of Q4 2016.
  • BlackRock Institutional Trust bought 28,539 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $534K.
  • NeuroDerm Ltd. Ordinary Shares made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3098 holding.
  • BlackRock Institutional Trust first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.